Dr. Hutnik has cared medically and surgically for patients suffering from the most common worldwide cause of blinding eye disease. Her translational research has focused on novel treatments. Her leadership roles have included President of the Canadian Glaucoma Society, Board member of the Glaucoma Research Society of Canada and advisor in the creation of Ontario Glaucoma Quality standards, as well as the Canadian Agency for Drugs and Technologies in Health for Minimally Invasive Glaucoma Surgeries. She brings this experience to her current roles as Governing Chair of the Academic Medical Organization of Southwestern Ontario and representation on the Eye Physicians of Surgeons of Ontario.